Literature DB >> 30414844

Requirement of Pitx2 for skeletal muscle homeostasis.

Chih-Ning Chang1, Arun J Singh2, Michael K Gross2, Chrissa Kioussi3.   

Abstract

Skeletal muscle is generated by the successive incorporation of primary (embryonic), secondary (fetal), and tertiary (adult) fibers into muscle. Conditional excision of Pitx2 function by an MCKCre driver resulted in animals with histological and ultrastructural defects in P30 muscles and fibers, respectively. Mutant muscle showed severe reduction in mitochondria and FoxO3-mediated mitophagy. Both oxidative and glycolytic energy metabolism were reduced. Conditional excision was limited to fetal muscle fibers after the G1-G0 transition and resulted in altered MHC, Rac1, MEF2a, and alpha-tubulin expression within these fibers. The onset of excision, monitored by a nuclear reporter gene, was observed as early as E16. Muscle at this stage was already severely malformed, but appeared to recover by P30 by the expansion of adjoining larger fibers. Our studies demonstrate that the homeodomain transcription factor Pitx2 has a postmitotic role in maintaining skeletal muscle integrity and energy homeostasis in fetal muscle fibers.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autophagy; Mitochondria; Mouse; Pitx2; Skeletal muscle

Mesh:

Substances:

Year:  2018        PMID: 30414844      PMCID: PMC6289786          DOI: 10.1016/j.ydbio.2018.11.001

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  63 in total

1.  Lbx1 specifies somatosensory association interneurons in the dorsal spinal cord.

Authors:  Michael K Gross; Mirella Dottori; Martyn Goulding
Journal:  Neuron       Date:  2002-05-16       Impact factor: 17.173

2.  Prediction of active nodes in the transcriptional network of neural tube patterning.

Authors:  Chrissa Kioussi; Hung-Ping Shih; John Loflin; Michael K Gross
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-28       Impact factor: 11.205

3.  Function of Rieger syndrome gene in left-right asymmetry and craniofacial development.

Authors:  M F Lu; C Pressman; R Dyer; R L Johnson; J F Martin
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

4.  Absence of MEF2 binding to the A/T-rich element in the muscle creatine kinase (MCK) enhancer correlates with lack of early expression of the MCK gene in embryonic mammalian muscle.

Authors:  S Ferrari; S Molinari; R Melchionna; M G Cusella-De Angelis; R Battini; L De Angelis; R Kelly; G Cossu
Journal:  Cell Growth Differ       Date:  1997-01

5.  A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance.

Authors:  J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn
Journal:  Mol Cell       Date:  1998-11       Impact factor: 17.970

6.  Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism.

Authors:  K Kitamura; H Miura; S Miyagawa-Tomita; M Yanazawa; Y Katoh-Fukui; R Suzuki; H Ohuchi; A Suehiro; Y Motegi; Y Nakahara; S Kondo; M Yokoyama
Journal:  Development       Date:  1999-12       Impact factor: 6.868

7.  Identification of a Wnt/Dvl/beta-Catenin --> Pitx2 pathway mediating cell-type-specific proliferation during development.

Authors:  Chrissa Kioussi; Paola Briata; Sung Hee Baek; David W Rose; Natasha S Hamblet; Thomas Herman; Kenneth A Ohgi; Chijen Lin; Anatoli Gleiberman; Jianbo Wang; Veronique Brault; Pilar Ruiz-Lozano; H D Nguyen; Rolf Kemler; Christopher K Glass; Anthony Wynshaw-Boris; Michael G Rosenfeld
Journal:  Cell       Date:  2002-11-27       Impact factor: 41.582

8.  Dosage requirement of Pitx2 for development of multiple organs.

Authors:  P J Gage; H Suh; S A Camper
Journal:  Development       Date:  1999-10       Impact factor: 6.868

9.  Loss of abdominal muscle in Pitx2 mutants associated with altered axial specification of lateral plate mesoderm.

Authors:  Diana Eng; Hsiao-Yen Ma; Jun Xu; Hung-Ping Shih; Michael K Gross; Chrissa Kioussi; Chrissa Kiouss
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  Genome Architecture Mediates Transcriptional Control of Human Myogenic Reprogramming.

Authors:  Sijia Liu; Haiming Chen; Scott Ronquist; Laura Seaman; Nicholas Ceglia; Walter Meixner; Pin-Yu Chen; Gerald Higgins; Pierre Baldi; Steve Smale; Alfred Hero; Lindsey A Muir; Indika Rajapakse
Journal:  iScience       Date:  2018-08-08
View more
  5 in total

Review 1.  Pitx genes in development and disease.

Authors:  Thai Q Tran; Chrissa Kioussi
Journal:  Cell Mol Life Sci       Date:  2021-04-12       Impact factor: 9.261

2.  Image-based pooled whole-genome CRISPRi screening for subcellular phenotypes.

Authors:  Gil Kanfer; Shireen A Sarraf; Yaakov Maman; Heather Baldwin; Eunice Dominguez-Martin; Kory R Johnson; Michael E Ward; Martin Kampmann; Jennifer Lippincott-Schwartz; Richard J Youle
Journal:  J Cell Biol       Date:  2021-02-01       Impact factor: 10.539

3.  Chronological Expression of PITX2 and SIX1 Genes and the Association between Their Polymorphisms and Chicken Meat Quality Traits.

Authors:  Haiyue Cao; Wei Zhou; Yuge Tan; Xiuli Xu; Haiguang Mao; Xinyang Dong; Ningying Xu; Zhaozheng Yin
Journal:  Animals (Basel)       Date:  2021-02-08       Impact factor: 2.752

4.  Xanthohumol ameliorates Diet-Induced Liver Dysfunction via Farnesoid X Receptor-Dependent and Independent Signaling.

Authors:  Ines L Paraiso; Thai Q Tran; Armando Alcazar Magana; Payel Kundu; Jaewoo Choi; Claudia S Maier; Gerd Bobe; Jacob Raber; Chrissa Kioussi; Jan F Stevens
Journal:  Front Pharmacol       Date:  2021-04-20       Impact factor: 5.988

5.  Pitx2 Differentially Regulates the Distinct Phases of Myogenic Program and Delineates Satellite Cell Lineages During Muscle Development.

Authors:  Felícitas Ramírez de Acuña; Francisco Hernandez-Torres; Lara Rodriguez-Outeiriño; Jorge N Dominguez; Lidia Matias-Valiente; Cristina Sanchez-Fernandez; Diego Franco; Amelia E Aranega
Journal:  Front Cell Dev Biol       Date:  2022-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.